PROJECT DESCRIPTION
COVID-19 Vaccine hesitancy needs to be addressed
Developing a safe and efficacious vaccine against COVID-19 in record time has been a success, but swift and comprehensive rollout of the vaccine has been marred by a number of challenges. On the supply side, these include funding, accessibility, and the logistical complexity of transporting, storing, and administering vaccines. On the demand side, one key challenge is vaccine hesitancy and resistance. Low confidence in COVID-19 vaccines, and low willingness to receive them, is a significant and growing risk to beating the pandemic globally.
79
%
OF RESPONDENTS WOULD TAKE A COVID-19 VACCINE
4-38
%
VACCINE
HESITANCY RANGE
48.2
%
AGREED TO VACCINATE ON ITS AVAILABILITY
Rollover Option 1
PROJECT APPROACH
Psycho-behavioral segmentation methodology
Follow along with us as we move through the different stages of this project from developing an in-depth understanding of the problem context to supporting the implementation of interventions. The stage we are currently working on is highlighted here.
Roll over each step to learn more
Research
2
Research
Ur sequasi dipsamusa vollecus rat que re ea istes dolest porehen istrum nam, od mi, illibus aut la et at moluptature volum acil idunt. Rum ilit eum doluptas eostiatem. Ut occullu ptatis pa vitatem excerum qui officiet anihit harcil molor asit rem iliqui te vellam dolo etur. Ommolup tiossuntur sum.
Design Research and Outputs
3
Design Research and Outputs
Ur sequasi dipsamusa vollecus rat que re ea istes dolest porehen istrum nam, od mi, illibus aut la et at moluptature volum acil idunt. Rum ilit eum doluptas eostiatem. Ut occullu ptatis pa vitatem excerum qui officiet anihit harcil molor asit rem iliqui te vellam dolo etur.
Research
Planning
1
Research Planning
Ur sequasi dipsamusa vollecus rat que re ea istes dolest porehen istrum nam, od mi, illibus aut la et at moluptature volum acil idunt. Rum ilit eum doluptas eostiatem. Ut occullu ptatis pa vitatem excerum qui officiet anihit harcil molor asit rem iliqui te vellam dolo etur. Ommolup tiossuntur sum.
Dissemination and Support
4
Dissemination and Support
Ur sequasi dipsamusa vollecus rat que re ea istes dolest porehen istrum nam, od mi, illibus aut la et at moluptature volum acil idunt. Rum ilit eum doluptas eostiatem. Ut occullu ptatis pa vitatem excerum qui officiet anihit harcil molor asit rem iliqui te vellam dolo etur. Ommolup tiossuntur sum.
"But even after we have overcome the imminent challenges of sufficient supply, efficient rollout and equitable access, a range of well-designed programme strategies will be needed to drive acceptance and uptake."
World Health Organization
https://www.who.int/news-room/feature-stories/detail/vaccine-acceptance-is-the-next-hurdle
The Latest
